BlackRock’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.3M | Buy |
5,348,561
+788,584
| +17% | +$3.33M | ﹤0.01% | 3019 |
|
|
2025
Q4 | $12.5M | Buy |
4,559,977
+193,400
| +4% | +$552K | ﹤0.01% | 3357 |
|
|
2025
Q3 | $15M | Buy |
4,366,577
+72,426
| +2% | +$264K | ﹤0.01% | 3251 |
|
|
2025
Q2 | $14.8M | Buy |
4,294,151
+322,626
| +8% | +$852K | ﹤0.01% | 3196 |
|
|
2025
Q1 | $8.46M | Sell |
3,971,525
-133,722
| -3% | -$401K | ﹤0.01% | 3398 |
|
|
2024
Q4 | $13.1M | Buy |
4,105,247
+65,273
| +2% | +$533K | ﹤0.01% | 3282 |
|
|
2024
Q3 | $53.9M | Buy |
4,039,974
+554,028
| +16% | +$7.37M | ﹤0.01% | 2426 |
|
|
2024
Q2 | $34.8M | Buy |
3,485,946
+2,696,477
| +342% | +$39M | ﹤0.01% | 2638 |
|
|
2024
Q1 | $9.39M | Buy |
789,469
+335,630
| +74% | +$2.86M | ﹤0.01% | 3380 |
|
|
2023
Q4 | $1.82M | Hold |
453,839
| – | – | ﹤0.01% | 4074 |
|
|
2023
Q3 | $1.24M | Sell |
453,839
-79,939
| -15% | -$373K | ﹤0.01% | 4177 |
|
|
2023
Q2 | $3.57M | Buy |
533,778
+33,345
| +7% | +$202K | ﹤0.01% | 3842 |
|
|
2023
Q1 | $3.19M | Buy |
500,433
+254,676
| +104% | +$1.04M | ﹤0.01% | 3835 |
|
|
2022
Q4 | $607K | Buy |
245,757
+1,423
| +0.6% | +$4.69K | ﹤0.01% | 4563 |
|
|
2022
Q3 | $562K | Sell |
244,334
-201
| -0.1% | -$687 | ﹤0.01% | 4690 |
|
|
2022
Q2 | $756K | Buy |
244,535
+613
| +0.3% | +$1.87K | ﹤0.01% | 4647 |
|
|
2022
Q1 | $885K | Buy |
243,922
+95
| +0% | +$346 | ﹤0.01% | 4707 |
|
|
2021
Q4 | $945K | Sell |
243,827
-2,453
| -1% | -$13.1K | ﹤0.01% | 4687 |
|
|
2021
Q3 | $1.55M | Sell |
246,280
-28
| -0% | -$191 | ﹤0.01% | 4422 |
|
|
2021
Q2 | $1.97M | Sell |
246,308
-57,748
| -19% | -$506K | ﹤0.01% | 4275 |
|
|
2021
Q1 | $3.31M | Buy |
304,056
+188,490
| +163% | +$2.85M | ﹤0.01% | 4118 |
|
|
2020
Q4 | $520K | Buy |
115,566
+178
| +0.2% | +$786 | ﹤0.01% | 4343 |
|
|
2020
Q3 | $673K | Buy |
115,388
+2
| +0% | +$13 | ﹤0.01% | 4209 |
|
|
2020
Q2 | $641K | Sell |
115,386
-217
| -0.2% | -$1.4K | ﹤0.01% | 4156 |
|
|
2020
Q1 | $613K | Buy |
115,603
+9,201
| +9% | +$69.5K | ﹤0.01% | 4015 |
|
|
2019
Q4 | $664K | Buy |
106,402
+17,919
| +20% | +$78.6K | ﹤0.01% | 4109 |
|
|
2019
Q3 | $284K | Buy |
88,483
+289
| +0.3% | +$1.05K | ﹤0.01% | 4268 |
|
|
2019
Q2 | $361K | Buy |
88,194
+394
| +0.4% | +$1.65K | ﹤0.01% | 4248 |
|
|
2019
Q1 | $321K | Buy |
87,800
+326
| +0.4% | +$1.27K | ﹤0.01% | 4169 |
|
|
2018
Q4 | $262K | Buy |
87,474
+403
| +0.5% | +$1.73K | ﹤0.01% | 4179 |
|
|
2018
Q3 | $452K | Buy |
87,071
+110
| +0.1% | +$613 | ﹤0.01% | 4153 |
|
|
2018
Q2 | $391K | Buy |
86,961
+250
| +0.3% | +$1.16K | ﹤0.01% | 4161 |
|
|
2018
Q1 | $364K | Sell |
86,711
-1,165
| -1% | -$5.14K | ﹤0.01% | 4093 |
|
|
2017
Q4 | $350K | Buy |
87,876
+165
| +0.2% | +$769 | ﹤0.01% | 4109 |
|
|
2017
Q3 | $453K | Buy |
87,711
+280
| +0.3% | +$1.57K | ﹤0.01% | 4079 |
|
|
2017
Q2 | $547K | Sell |
87,431
-8,006
| -8% | -$45.3K | ﹤0.01% | 3999 |
|
|
2017
Q1 | $563K | Buy |
+95,437
| New | +$559K | ﹤0.01% | 3932 |
|
Other funds holding CATX
APM
TCM
CC
OM
VCM
AAA
